Correspondence
Retina
.
2020 Apr;40(4):e13.
doi: 10.1097/IAE.0000000000002710.
Authors
Antonello Caruso
1
,
Norman A Mazer
Affiliation
1
Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
PMID:
31834136
PMCID:
PMC7099837
DOI:
10.1097/IAE.0000000000002710
No abstract available
Publication types
Comment
MeSH terms
Humans
Macular Degeneration*
Receptors, Vascular Endothelial Growth Factor*
Recombinant Fusion Proteins
Substances
Recombinant Fusion Proteins
aflibercept
Receptors, Vascular Endothelial Growth Factor